Baird Financial Group, Inc. Amgen Inc Transaction History

Baird Financial Group, Inc.

$47.6 Billion
Q2 2024

A detailed history of Baird Financial Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Baird Financial Group, Inc. holds 334,257 shares of AMGN stock, worth $106 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

334,257

Previous 343,087 2.57%

Holding current value

$106 Million

Previous $97.5 Million 7.07%

% of portfolio

0.22%

Previous 0.21%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $2.32 Million - $2.82 Million	-8,830 Reduced 2.57%	334,257 $104 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $3.3 Million - $3.98 Million	-12,262 Reduced 3.45%	343,087 $97.5 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $11.3 Million - $12.7 Million	44,105 Added 14.17%	355,349 $102 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $271,563 - $337,153	1,242 Added 0.4%	311,244 $83.6 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $14.5 Million - $17.1 Million	-67,447 Reduced 17.87%	310,002 $68.8 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $3.06 Million - $3.73 Million	-13,567 Reduced 3.47%	377,449 $91.2 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $8.11 Million - $9.14 Million	-36,111 Reduced 8.36%	395,678 $89.2 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $12 Million - $13.4 Million	52,024 Added 13.7%	431,789 $105 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $11.2 Million - $12.4 Million	-51,173 Reduced 11.87%	379,765 $91.8 Million
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $2.79 Million - $3.19 Million	14,027 Added 3.36%	430,938 $96.9 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $634,687 - $743,613	2,990 Added 0.72%	416,911 $88.7 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $12.1 Million - $13.4 Million	51,809 Added 14.31%	413,921 $101 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $4.8 Million - $5.6 Million	-21,642 Reduced 5.64%	362,112 $90.1 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $2.18 Million - $2.6 Million	10,082 Added 2.7%	383,754 $88.2 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $2.33 Million - $2.59 Million	9,918 Added 2.73%	373,672 $95 Million
Q2 2020 Oct 22, 2020	SELL	$197.81 - $242.74 $7.89 Million - $9.68 Million	-39,894 Reduced 9.88%	363,754 $85.8 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $3.77 Million - $4.63 Million	19,062 Added 4.96%	403,648 $96.9 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $5.4 Million - $7.17 Million	-29,647 Reduced 7.16%	384,586 $77.7 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $1.89 Million - $2.43 Million	9,998 Added 2.47%	414,233 $99.9 Million
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $1.9 Million - $2.28 Million	10,924 Added 2.78%	404,235 $78.2 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $12.2 Million - $14.3 Million	72,999 Added 22.79%	393,311 $72.5 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $5.58 Million - $6.29 Million	-30,843 Reduced 8.78%	320,312 $60.8 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $6.02 Million - $7.03 Million	33,736 Added 10.63%	351,155 $68.4 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $5.17 Million - $5.83 Million	-27,929 Reduced 8.09%	317,419 $65.7 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $2.47 Million - $2.78 Million	14,885 Added 4.5%	345,348 $63.7 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $1.18 Million - $1.38 Million	6,963 Added 2.15%	330,463 $56.3 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $1.19 Million - $1.33 Million	-7,067 Reduced 2.14%	323,500 $56.3 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $1.5 Million - $1.71 Million	-8,970 Reduced 2.64%	330,567 $61.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	339,537	339,537 $58.5 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Amgen Inc Transaction History